The efficacy of systemic therapy varies among patients with rare skin cancers, but patients with cutaneous adnexal carcinoma have poor outcomes regardless of the therapy they receive, according to ...
Colorectal cancer (CRC) is one of the most common malignant cancers and its incidence is steadily rising particularly in ...
Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to ...
Zacks Investment Research on MSN
REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.
Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...
Detailed results from bezuclastinib’s positive SUMMIT trial evaluating bezuclastinib in patients with NonAdvanced Systemic ...
Please provide your email address to receive an email when new articles are posted on . One specialist highlighted cases in which systemic treatments, such as corticosteroids, are better. Another ...
Cutaneous fungal infections that generally require systemic antifungal therapy include tinea capitis and onychomycosis. Tinea capitis, which is most often caused by Trichophyton tonsurans,is among the ...
Effective therapy is about more than insight or advice. It is about transformation—a felt shift in how we relate to ourselves and others in real time. Systemic therapy, grounded in family systems ...
Trial met primary endpoint achieving statistically significant improvement in disease activity, with 67.1% of patients responding with ...
HealthDay on MSN
Guidelines Developed for Postmastectomy Radiation Therapy
HealthDay News — In a clinical practice guideline published online Sept. 16 in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy radiation therapy (PMRT).
17hon MSN
Teclistamab T-cell therapy shows promise in patients with drug-resistant autoimmune disease
Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results